89bio, Inc.·4

Feb 4, 9:35 PM ET

Martins Ryan 4

4 · 89bio, Inc. · Filed Feb 4, 2025

Insider Transaction Report

Form 4
Period: 2025-02-01
Martins Ryan
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2025-02-01+80,000277,620 total
  • Award

    Stock Option (Right to Buy)

    2025-02-01+300,000300,000 total
    Exercise: $9.60Exp: 2035-02-01Common Stock (300,000 underlying)
  • Tax Payment

    Common Stock

    2025-02-01$9.60/sh3,338$32,045274,282 total
Footnotes (3)
  • [F1]Represents restricted stock units that vest in equal semi-annual installments over three years, subject to the Reporting Person's continued service to the Issuer.
  • [F2]These shares were withheld from the vesting of restricted stock units to cover the estimated tax withholding obligation.
  • [F3]Represents a right to purchase a total of 300,000 shares of the Issuer's Common Stock, one quarter of which will vest on February 1, 2026, with the remaining three quarters vesting in equal quarterly installments over the following three years, subject to the Reporting Person's continued service to the Issuer.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4